Ricardo Parrondo Selected Research

Ricardo Parrondo Research Topics

Disease

6	Multiple Myeloma 11/2023 - 01/2013
5	Prostatic Neoplasms (Prostate Cancer) 01/2015 - 11/2007
4	Neoplasms (Cancer) 01/2013 - 11/2007
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 01/2022
2	Disease Progression 10/2022 - 01/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 11/2023
1	Plasmacytoma 11/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Tumor Lysis Syndrome 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Lymphoma (Lymphomas) 01/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 10/2020
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2020
1	Acute Kidney Injury (Acute Renal Failure) 07/2017
1	Cardiac Arrhythmias (Arrythmia) 07/2017
1	Pneumonia (Pneumonitis) 07/2017
1	Respiratory Insufficiency (Respiratory Failure) 07/2017
1	Septic Shock (Toxic Shock Syndrome) 07/2017
1	Sepsis (Septicemia) 07/2017
1	Hypoxia (Hypoxemia) 01/2016
1	Breast Neoplasms (Breast Cancer) 05/2010
1	Neoplasm Metastasis (Metastasis) 05/2010
1	Lung Neoplasms (Lung Cancer) 05/2010
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2010

Drug/Important Bio-Agent (IBA)

3	Lenalidomide (CC 5013)FDA Link 04/2023 - 01/2022
3	Bortezomib (Velcade)FDA Link 01/2023 - 01/2013
3	Apoptosis Regulatory ProteinsIBA 01/2016 - 01/2013
2	Dexamethasone (Maxidex)FDA LinkGeneric 04/2023 - 01/2022
2	ibrutinibIBA 10/2022 - 01/2022
2	venetoclaxIBA 10/2022 - 01/2022
2	Antimitotic AgentsIBA 01/2013 - 07/2010
1	thiamine triphosphorate (TTP)IBA 11/2023
1	pomalidomideIBA 04/2023
1	daratumumabIBA 04/2023
1	LisaftoclaxIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022
1	SteroidsIBA 10/2020
1	ElementsIBA 01/2016
1	RE1-silencing transcription factorIBA 01/2016
1	GalactosidasesIBA 01/2016
1	Oxygen (Dioxygen)IBA 01/2016
1	ABT-737IBA 01/2013
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2013
1	Betulinic AcidIBA 01/2013
1	Androgen Receptors (Androgen Receptor)IBA 01/2013
1	Oncogene Proteins (Oncogene Protein)IBA 01/2013
1	Ubiquitinated ProteinsIBA 01/2013
1	Cyclin D1IBA 01/2013
1	UbiquitinIBA 01/2013
1	Deubiquitinating EnzymesIBA 01/2013
1	Docetaxel (Taxotere)FDA Link 07/2010
1	NF-kappa B (NF-kB)IBA 07/2010
1	2-MethoxyestradiolIBA 07/2010
1	AndrogensIBA 07/2010
1	Lapatinib (GW572016)FDA Link 05/2010
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2010
1	Epidermal Growth Factor (EGF)IBA 05/2010
1	Tyrosine Kinase InhibitorsIBA 05/2010
1	Gefitinib (Iressa)FDA Link 05/2010
1	GlobinsIBA 11/2007
1	Tumor Viral Antigens (Large T Antigen)IBA 11/2007
1	DNA (Deoxyribonucleic Acid)IBA 11/2007

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2022
3	Castration 01/2015 - 07/2010
3	Drug Therapy (Chemotherapy) 01/2015 - 07/2010
2	Transplantation 01/2022 - 07/2017
1	Radiotherapy 11/2023
1	Stem Cell Transplantation 01/2022
1	Artificial Respiration (Mechanical Ventilation) 07/2017
1	Hematopoietic Stem Cell Transplantation 07/2017